Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
Objective Although surveillance after radical prostatectomy routinely includes repeated prostate specific antigen (PSA)-testing for many years, biochemical recurrence often occurs without further clinical progression. We therefore hypothesised that follow-up can be shortened for many patients withou...
Saved in:
Main Authors: | Mats Steinholtz Ahlberg, Hans-Olov Adami, Hans Garmo, Lars Holmberg, Anna Bill-Axelson, Ove Andren, Gunnar Steineck, Jan-Erik Johansson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-12-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/12/e057242.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The accuracy of ultrasensitive PSA in predicting disease progression after radical prostatectomy
by: Heikki Seikkula, et al.
Published: (2024-11-01) -
The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy
by: Jennifer M. Post, et al.
Published: (2011-01-01) -
Prognostic Factors for the Development of Biochemical Recurrence after Radical Prostatectomy
by: Ahmed F. Kotb, et al.
Published: (2011-01-01) -
Calculated Tumor Volume Is an Independent Predictor of Biochemical Recurrence in Patients Who Underwent Retropubic Radical Prostatectomy
by: Nobumichi Tanaka, et al.
Published: (2012-01-01) -
Prognostic significance of the logistic regression model for assessing the risk of recurrence in patients with prostate cancer after radical prostatectomy
by: S. A. Reva, et al.
Published: (2022-12-01)